Bank of America’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bank of America’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-11,300	Closed	-$17K	–	8139
2014 Q4	$17K	Sell	11,300 -3,500	-24%	-$5.26K	﹤0.01%	6868
2014 Q3	$30K	Sell	14,800 -63,700	-81%	-$129K	﹤0.01%	6834
2014 Q2	$240K	Sell	78,500 -148,200	-65%	-$453K	﹤0.01%	5386
2014 Q1	$567K	Buy	226,700 +205,800	+985%	+$515K	﹤0.01%	4479
2013 Q4	$104K	Buy	+20,900	New	+$104K	﹤0.01%	6109
2013 Q3	–	Sell	-145,200	Closed	-$322K	–	8383
2013 Q2	$322K	Buy	+145,200	New	+$322K	﹤0.01%	5171

Bank of America's RXII Position: Q4 2016 in Review

Bank of America sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 9,839 shares — an estimated $4K sold.

Bank of America first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $723K in Q2 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Bank of America reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Bank of America sold 9,839 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
Bank of America first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
Bank of America's GALENA BIOPHARMA INC COM position peaked at $723K in Q2 2013.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.